Company Overview of Aptalis Pharma S.r.l.
Aptalis Pharma S.r.l. develops, manufactures, and commercializes pharmaceutical and biopharmaceutical products. It offers drug delivery technologies, such as controlling drug release, enhanced bioavailability, dosage form technology, and drug conjugation. The company provides products for the treatment of cystic fibrosis and chronic pancreatitis. It serves patients, care providers, and payors. The company also provides contract manufacturing services. It supplies its products to the United States, Japan, Asia, the Middle East, North American, South American, and Europe. Aptalis Pharma S.r.l. was formerly known as Eurand S.p.A. The company was founded in 1969 and is headquartered in Milan, It...
Via Martin Luther King, 13
Pessano con Bornago
Milan, MI 20060
Founded in 1969
39 02 954281
39 02 95 74 50 12
Key Executives for Aptalis Pharma S.r.l.
Chairman and Chief Executive Officer
Corporate Technology Director
Compensation as of Fiscal Year 2014.
Aptalis Pharma S.r.l. Key Developments
Aptalis Pharma S.r.l Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-12-2013 11:00 AM
Feb 7 13
Aptalis Pharma S.r.l Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-12-2013 11:00 AM. Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries